CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early-Stage hepatitis b drug trial halted
Disease control TerminatedThis early-stage study tested a new medicine called RO7565020 in healthy people and those with chronic hepatitis B. The goal was to check safety and how the body processes the drug. The trial was stopped early, and results are not yet available.
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 02:16 UTC
-
Hepatitis b cure attempt falls short: study terminated early
Disease control TerminatedThis study tested whether giving hepatitis B antibodies (HBIG) could clear the hepatitis B surface antigen (HBsAg) in people with chronic hepatitis B. It included 13 adults who had been on antiviral therapy for at least a year. The treatment was given for 12 weeks, but the study …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated May 26, 2026 02:11 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called ARC-520, given alongside standard hepatitis B medications (entecavir or tenofovir), in people with chronic hepatitis B. The goal was to see if it could lower the amount of hepatitis B surface antigen in the blood. Only 4 people took p…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC